The following question is based on the shown pulmonary function tests (PFTs). Assume in each case that the test result is adequate and reproducible.
Key:
FVC |
L |
Forced Vital Capacity |
FEV1 |
L |
Forced Expiratory volume in 1 second |
FEV1/FVC |
% |
Ratio of the above |
RV |
L |
Residual volume at end expiration |
TLC |
L |
Total Lung Capacity |
DLCO corr |
ml/min/mmHg |
Diffusing capacity for carbon monoxide, corrected for Hb |
A 39-year-old female has presented in ED with severe, acute on chronic shortness of breath, now affecting her at rest. She has a 15-pack year history of smoking. She has had PFTs performed recently as an outpatient. Her chest X-ray shows marked bi-basal hyper-lucency.
Predicted |
Actual |
% Predicted |
Post Bronchodilator |
% Change |
|
FVC (L) |
3.15 |
1.50 |
48 |
0.83 |
-10 |
FEV1 (L) |
2.65 |
0.52 |
20 |
0.53 |
+2 |
FEV1/FVC (%) |
83 |
54 |
14 |
||
RV (L) |
1.49 |
3.13 |
210 |
||
TLC (L) |
4.44 |
4.74 |
107 |
||
DLCO corr (ml/min/mmHg) |
24.85 |
6.70 |
27 |
Severe, non-reversible obstructive lung disease
Smoking related lung disease
Alpha 1 antitrypsin deficiency (2 marks)
Formal pulmonary function tests have also been asked about in Question 21.2 from the first paper of 2014 and the identical Question 9.1 from the first paper of 2011.
To approach this systematically:
In summary, this patient has hyperinflated lungs with a severe irreversible obstructive pattern. The history we are given (smoker, but too young to have such severe bibasal bullous emphysema) suggests something might be congenitally broken in her lungs. As such, the college offer α-1 antitrypsin deficiency as one of the differentials. A list of (vaguely) plausible differentials might include:
Pellegrino, Riccardo, et al. "Interpretative strategies for lung function tests."European Respiratory Journal 26.5 (2005): 948-968.
The American Thoracic Society has a page which features an excellent bibliography of the articles which support their interpretation standards.